Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus

Journal of the American Society of Nephrology

Volumn 8, Issue 12, 1997, Pages 1855-1862

  Vargas Poussou, Rosa ^a,b   Forestier, Lionel ^a   Dautzenberg, Marie Dominique ^b   Niaudet, Patrick ^b   Déchaux, Michèle ^b   Antignac, Corinne ^a,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN; AQUAPORIN 2; UNCLASSIFIED DRUG; VASOPRESSIN V2 RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; GENE ISOLATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; KIDNEY TUBULE ABSORPTION; MALE; MEMBRANE PERMEABILITY; NEPHROGENIC DIABETES INSIPIDUS; NEWBORN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR GENE; X CHROMOSOME RECESSIVE DISORDER;

EID: 0031429315     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Reeves WB, Andreoli TE: Nephrogenic diabetes insipidus. In: The Metabolic Basis of Inherited Disease, 7th Ed., edited by Scriver CR, Beaudet AL, Sly WAS, Valle D, New York, McGraw-Hill, 1995, pp 3045-3070
2. Hoekstra JA, van Lieburg AF, Monnens LA, Hulstijn-Dirkmaat GM, Knoers VVAM: Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 61: 81-88, 1996
3. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramain A, Brabet P, Rosenthal W: Molecular cloning of the receptor for human antidiuretic hormone. Nature 357: 333-335, 1992
4. Knepper MA, Nielsen S, Chou CL, DiGiovanni SR: Mechanism of vasopressin action in the renal collecting duct. Semin Nephrol 14: 302-321, 1994
5. Kuwahara M, Fushimi YT, Bai L, Marumo F, Sasaki S: cAMP-dependent phosphorylation stimulates water permeability of aquaporin-collecting duct water channel protein expressed in Xenopus oocytes. J Biol Chem 270: 10384-10387, 1995
6. Deen P, Verdijk MAJ, Knoers NVAM, Wieringa B, Monnens LAH, van Os CH, van Oost BA: Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264: 92-95, 1994
7. Uchida S, Sasaki S, Fushimi K, Marumo F: Isolation of human aquaporin-CD gene. J Biol Chem 269: 23451-23455, 1994
8. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, Birnbaumer M, Bichet D: Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359: 233-235, 1992
9. van den Ouweland AM, Dreesen JCFM, Verdijk M, Knoers NVAM, Monnens LAH, Rocchi M, van Oost BA: Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet 2: 99-102, 1992
10. Pan Y, Metzenberg A, Das S, Jing B, Gitschier J: Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet 2: 103-106, 1992
11. Holtzman EJ, Harris HW, Kolakowski LF, Guay-Woodford L, Botelho B, Ausiello DA: A molecular defect in the vasopressin V2-receptor gene causing nephrogenic diabetes insipidus. N Engl J Med 328: 1534-1537, 1993
12. Merendino JJ, Spiegel AM, Crawford JD, O'Carrol AM, Brownstein MJ, Lolait SJ: A mutation in the vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus. N Engl J Med 328: 1538-1541, 1993
13. Bichet DG, Arthus MF, Lonergan M, Hendy GH, Paradis AJ, Fujiwara TM, Morgan K, Gregory MC, Rosenthal W, Didwania A: X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest 92: 1262-1268, 1993
14. Tsukaguchi H, Matsubara H, Aritaki S, Kimura T, Abe S, Inada M: Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Biochem Biophys Res Commun 197: 1000-1010, 1993
15. Knoers N, van den Ouweland A, Verdijk M, Monnens L, van Oost B: Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus. Kidney Int 46: 170-176, 1994
16. Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W, Goodyer P, Nivet H, Benoit S, Giampietro P, Simonetti S, Fish A. Whitley CB, Jaeger P, Gertner J, New M, Dibona FJ, Kaplan BS, Robertson GL, Hendy GN, Fujiwara TM, Morgan K: Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 55: 278-286, 1994
17. Wildin RS, Antush MJ, Bennett RL, Schoof JM, Scott CR: Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet 55: 266-277, 1994
18. Faà V, Ventruto ML, Loche S, Bozzola M, Podda R, Cao A, Rosatelli MC: Mutations in the vasopressin V2 receptor gene in three families of Italian descent with nephrogenic diabetes insipidus. Hum Mol Genet 3: 1685-1686, 1994
19. Wenkert D, Merendino JJ, Shenker A, Thambi N, Robertson GL, Moses AM, Spiegel AM: Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidus. Hum Mol Genet 3: 1429-1430, 1994
20. Holtzman EJ, Kolakowski LF, Geifman-Holtzman O, O'Brien DG, Rasoulpour M, Guillot AP, Ausiello DA: Mutations in the vasopressin V2 receptor gene in two families with nephrogenic diabetes insipidus. J Am Soc Nephrol 5: 169-176, 1994
21. Yuasa H, Ito M, Oiso Y, Kurokawa M, Watanabe T, Oda Y, Ishizuka T, Tani N, Ito S, Shibata A, Saito H: Novel mutations in the V2 vasopressin receptor gene in two pedigrees with congenital nephrogenic diabetes insipidus. J Clin Endocrinol Metab 79: 361-365, 1994
22. Tajima T, Nakae J, Takekoshi Y, Takahashi Y, Yuri K, Nagashima T, Fujieda K: Three novel AVPR2 mutations in three Japanese families with X-linked nephrogenic diabetes insipidus. Pediatr Res 39: 522-526, 1996
23. Fujiwara TM, Morgan K, Bichet DG: Molecular analysis of X-linked nephrogenic diabetes insipidus. Eur J Endocrinol 134: 675-677, 1996
24. van den Ouweland AM, Knoop MT, Knoers NVAM, Markslag PWB. Rocchi M, Warren ST, Ropers HH, Fahrenholz F, Monnens LAH, van Oost B: Colocalization of the gene for nephrogenic diabetes insipidus and the vasopressin type 2 receptor gene in the Xq28 region. Genomics 13: 1350-1352, 1992
25. van Lieburg AF, Verdijk MAJ, Knoers NVAM, van Essen AJ, Proesmans W, Mallmann R, Monnens LAH, van Oost BA, van Os CH, Deen PMT: Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet 55: 648-652, 1994
26. Bichet DG, Arthus M, Lonergan M, Balfe W, Skorecki K, Nivet H, Robertson G, Oksche A, Rosenthal W, Fujiwara M, Morgan K, Sasaki S: Autosomal dominant and autosomal recessive nephrogenic diabetes insipidus: Novel mutations in the AQP2 gene [Abstract]. J Am Soc Nephrol 6: 717, 1995
27. Kobrinsky NL, Doyle JJ, Israels ED, Winter JSD, Cheang MS, Walker KD, Bishop AJ: Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus. Lancet i: 1293-1294, 1985
28. Bichet DG, Razi M, Arthus MF, Papukna V, Kortas C, Barjon JN: Hemodynamic and coagulation responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 318: 881-887, 1988
29. Brenner B, Seligsohn U, Hochberg Z: Normal response of factor VIII and von Willebrand factor to 1-desamino-8-D- argininevasopressin in nephrogenic diabetes insipidus. J Clin Endocrinol Metab 67: 191-193, 1988
30. Moses AM, Miller JL, Levine MA: Two distinct pathophysiological mechanisms in congenital nephrogenic diabetes insipidus. J Clin Endocrinol Metab 66: 1259-1264, 1988
31. Bichet DG, Razi M, Arthus MF, Lonergan M, Tittley P, Smiley RK, Rock G, Hirsch DJ: Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Kidney Int 36: 859-866, 1989
32. Knoers N, Brommer EJP, Willems H, van Oost BA, Monnens LAH: Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus. Nephron 54: 322-326, 1990
33. Knoers N, Monnens LAH: A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney. Eur J Pediatr 150: 370-373, 1991
34. Knebelman B, Deschenes G, Gros F, Hors MC, Grünfeld JP, Tryggvasson K, Gubler MC: Substitution of arginine for glycine 325 in the collagen α5(IV) chain associated with X-linked Alport syndrome: Characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments. Am J Hum Genet 51: 135-142, 1992
35. Carmichael MC, Kumar R: Molecular biology of vasopressin receptors. Semin Nephrol 14: 341-348, 1994
36. Mouillac B, Chini B, Balestre MN, Elands J, Trumpp-Kallmeyer S, Hoflack J, Hibert M, Jard S, Barberis C: The binding site of neuropeptide vasopressin Via receptor. J Biol Chem 270: 25771-25777, 1995
37. Tsukaguchi H, Matsubara H, Inada M: Expression studies of two vasopressin V2 receptor gene mutations, R202C and 804insG, in nephrogenic diabetes insipidus. Kidney Int 48: 554-562, 1995
38. Bichet DG, Artus MF, Lonergan M: Is testing with dDAVP useful in detecting carriers of the nephrogenic diabetes insipidus gene? Nephron 58: 372-373, 1991
39. Reizer J, Reizer A, Saier MH Jr: The MIP family of integral membrane channel proteins: Sequence comparisons, evolutionary relationships, reconstructed pathway of evolution, and proposed functional differentiation of the two repeated halves of the proteins. Crit Rev Biochem Mol Biol 28: 235-257, 1993
40. Bai L, Fushimi K, Sasaki S, Marumo F: Structure of aquaporin-2 vasopressin water channel. J Biol Chem 271: 5171-5176, 1996